Journal of Applied Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

J Appl Physiol 66: 1642-1648, 1989;
8750-7587/89 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hill, N. S.
Right arrow Articles by Gagnon, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hill, N. S.
Right arrow Articles by Gagnon, J.

Journal of Applied Physiology, Vol 66, Issue 4 1642-1648, Copyright © 1989 by American Physiological Society

ARTICLES

Supplemental oxygen reduces right ventricular hypertrophy in monocrotaline-injected rats

N. S. Hill, P. Jederlinic and J. Gagnon
Pulmonary Divisions, New England Medical Center, Boston, Massachusetts 01770.

We evaluated the possible contributory role of hypoxia in the development of monocrotaline-induced pulmonary hypertension. Male Sprague-Dawley rats were injected subcutaneously with monocrotaline (60 mg/kg) or saline in controls and were kept in oxygen-enriched (inspired O2 fraction of 0.35) or compressed air chambers. After 21 days, rats were anesthetized while spontaneously breathing room air, hemodynamic parameters and arterial blood gases were measured, and animals were killed. Right ventricular peak systolic pressures (RVPP), right ventricular-to-left ventricular plus septal weight ratios (RV/LV + S), hematocrits, lung dry weight-to-body weight ratios, and medial thickness of pulmonary arteries were significantly reduced in monocrotaline-injected rats exposed to mild hyperoxia compared with air. The air-exposed monocrotaline-injected rats had significantly more arterial hypoxemia than the other groups, and mild hyperoxia had no effect on any of the measured variables in saline-injected rats. To determine whether the effects of mild hyperoxia occurred early or late after monocrotaline injection, we moved separate groups of rats from air to mild hyperoxia and vice versa 10 days after monocrotaline injection. After 21 days, significant reductions in RVPP and RV/LV + S occurred only in rats exposed to mild hyperoxia during the latter 11 days after injection. Our findings suggest that hypoxia contributes to the development of pulmonary hypertension relatively late after monocrotaline injection in rats but that it does not influence the early injury.


This article has been cited by other articles:


Home page
 J. Appl. Physiol.Home page
N. S. Hill, R. R. Warburton, L. Pietras, and J. R. Klinger
Nonspecific endothelin-receptor antagonist blunts monocrotaline-induced pulmonary hypertension in rats
J Appl Physiol, October 1, 1997; 83(4): 1209 - 1215.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
G. L. Colice, N. Hill, Y.-J. Lee, H. Du, J. Klinger, J. C. Leiter, and L.-C. Ou
Exaggerated pulmonary hypertension with monocrotaline in rats susceptible to chronic mountain sickness
J Appl Physiol, July 1, 1997; 83(1): 25 - 31.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online